References
Sallah S, Husain A, Nguyen-Nam P (2004) Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation. Blood Coagul Fibrinolysis 15(7):577–582
Malone DL, Dune J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM (2003) Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54:898–907
Von Depka M. Novoseven (2002) Mode of action and use in acquired haemophilia. Intensive Care Med 28:222–227
Kenet G, Walden R, Eldad A, Martinowitz U (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879
Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M (2001) Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51:431–439
Grounds M (2003) Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review. Blood Rev 17:11–21
Friederich PW, Henny CP, Messelink FJ, Geerdink MG, Keller T, Kurth KH, Buller HR, Levi M (2003) Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 361:201–205
Deveras RA, Kessler CM (2002) Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 137:884–888
Hedner U. Recombinant factor VIIa (Novoseven) as a hemostatic agent. Dis Mon 49:39–48
Roberts HR, Monroe DM, White GC (2004) The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 104:3858–3864
Hoffman M (2003) A cell-based model of coagulation and the role of factor VIIa. Blood Rev 17(Suppl 1):1–5
Roberts HR (2001) Factor VIIa and the safety of treatment. Semin Hematol 38(suppl 12):48–50
Levi M (2003) Safety of recombinant factor VIIa. TATM 5:11–14
Martinowitz U, Michaelson M (2005) Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli multidisciplinary rFVIIa task force. J Thromb Haemost 3:640–648
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hatzipantelis, E.S., Gombakis, N., Sidi, V. et al. Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII. Intern Emerg Med 3, 171–173 (2008). https://doi.org/10.1007/s11739-008-0104-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-008-0104-8